not sure I understand the point or the development path of this SOFvac product.
//it's supposed to reduce inflammation after RNA vaccines but it's well known that the inflammatory reactions side effects following the two MRNA covid vaccines by Pfizer and Moderna were usually mild and short-lived.
//if the idea is to blunt the in inflammatory response what's to say it won't impair the response needed for a good protective immune response to the vaccine
not sure I understand the point or the development path of this...
Add NOX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
11.0¢ |
Change
0.005(4.76%) |
Mkt cap ! $32.14M | |||
| Open | High | Low | Value | Volume |
| 11.5¢ | 11.5¢ | 11.0¢ | $18.94K | 171.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 50000 | 11.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 12.5¢ | 66800 | 1 |
View Market Depth
| Last trade - 14.48pm 08/11/2024 (20 minute delay) ? |
| NOX (ASX) Chart |